Regulatory Digest

CSOFT life science blog aims to provide a better understanding of complex diseases, and regulatory polices from conducting experiments to introducing new type of drugs into the market.
Other Resources
Chinas New Human Genetic Resources Policy

Chinas New Human Genetic Resources Policy

CHINA’S NEW HUMAN GENETIC RESOURCES POLICY Fast and ProfessionalLocalization and TranslationServices | CSOFTcsoftintl.comLife Sciences Localization | Medical TranslationsTranslation services for the life science Industries. We specialize in medical device,...

read more
Breast Cancer Awareness Month

Breast Cancer Awareness Month

Breast Cancer Awareness Month ABOUT USCSOFT Life Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access...

read more
ABOUT US

CSOFT Life Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com